BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., provided a commercialization update on its recently acquired operating subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, highlighting encouraging early operating results. Preliminary May 2026 revenue reached approximately $22,344, a 76% increase from April's $12,670, despite operations commencing under UNLOCKD ownership only in the middle of May following the acquisition's closing. Additionally, on June 2, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of $29,411 under wholesale pricing terms.
The company emphasized that all financial figures are preliminary, unaudited, and subject to further review. John P. Gorst, CEO of UNLOCKD, noted, "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing." He added that the combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces the company's belief in the acquisition's potential.
Ancient Extracts USA offers a growing portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods under the brand philosophy of "Ancient Remedies for Modern Life." UNLOCKD believes the brand is well positioned to benefit from increasing consumer interest in functional mushrooms, adaptogens, botanical wellness products, and evidence-informed approaches to health and human performance.
Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, stated, "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth." He emphasized the company's objective to grow revenue, expand distribution, strengthen its portfolio of wellness assets, and execute with discipline.
Separately, UNLOCKD's Technologies division has begun preliminary planning for future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts and discussions with developers and potential strategic partners. These initiatives remain conceptual, and the company expects to pursue dedicated financing for such efforts rather than using capital intended for current operations. No assurances can be provided regarding the timing or success of any future technology initiatives.
UNLOCKD Inc. is a public operating company focused on identifying, acquiring, commercializing, and scaling consumer brands across wellness, cognitive health, functional products, performance nutrition, human optimization, and emerging health technology categories. For more information, visit www.unlockdinc.com and follow @BFCHco on X for verified company updates.
